a-Secretase Substrate |
1.0 mg |
165 |
Acetyl-Arg-(Glu-Edans)-Val-His-His-Gln-Lys-Leu-Val-Phe-(Dabcyl-Lys)-Arg-OH |
a-Secretase Substrate |
5.0 mg |
655 |
Acetyl-Arg-(Glu-Edans)-Val-His-His-Gln-Lys-Leu-Val-Phe-(Dabcyl-Lys)-Arg-OH |
Abarelix |
1.0 mg |
130 |
Acetyl-(D-Naphtyl-Ala )-(p-Chloro-D-Phenylalanine)-(Pyridyl-Ala)-Ser-(NMe-Tyr)-D-Asp-Leu-(Iso-Lys)-Pro-D-Ala-NH2 |
Abarelix |
5.0 mg |
530 |
Acetyl-(D-Naphtyl-Ala )-(p-Chloro-D-Phenylalanine)-(Pyridyl-Ala)-Ser-(NMe-Tyr)-D-Asp-Leu-(Iso-Lys)-Pro-D-Ala-NH2 |
Ac-Arg-Ala-Arg-AMC |
5.0 mg |
125 |
Acetyl-Arg-Ala-Arg-AMC |
Acetyl Beta Amyloid (25-35) |
1.0 mg |
55 |
Acetyl-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH |
Acetyl Beta Amyloid (25-35) |
5.0 mg |
205 |
Acetyl-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH |
Acetyl-Ala-Arg-AMC |
10.0 mg |
110 |
Acetyl-Ala-Arg-AMC |
Acetyl-Arg-Ala-Val-AMC |
5.0 mg |
110 |
Acetyl-Arg-Ala-Val-AMC |
Acetyl-Arg-Glu-Lys-Arg-AFC |
5.0 mg |
120 |
Acetyl-Arg-Glu-Lys-Arg-AFC |
Acetyl-Arg-Gly-Phe-Phe-Pro-AFC |
5.0 mg |
140 |
Acetyl-Arg-Gly-Phe-Phe-Pro-AFC |
Acetyl-Arg-Gly-Phe-Phe-Pro-AMC |
5.0 mg |
110 |
Acetyl-Arg-Gly-Phe-Phe-Pro-AMC |
Acetyl-Arg-Ser-Leu-Lys-AMC |
5.0 mg |
110 |
Acetyl-Arg-Ser-Leu-Lys-AMC |
Acetyl-Glu-Val-Asn-Leu-AFC |
5.0 mg |
120 |
Acetyl-Glu-Val-Asn-Leu-AFC |
Acetyl-Glu-Val-Asn-Leu-AMC |
5.0 mg |
110 |
Acetyl-Glu-Val-Asn-Leu-AMC |
Acetyl-Glu-Val-Asn-Leu-pNA |
5.0 mg |
90 |
Acetyl-Glu-Val-Asn-Leu-pNA |
Acetyl-Leu-Gln-Thr-Asp-AFC |
5.0 mg |
120 |
Acetyl-Leu-Gln-Thr-Asp-AFC |
Acetyl-Leu-Leu-Arg-AMC |
5.0 mg |
110 |
Acetyl-Leu-Leu-Arg-AMC |
Acetyl-Leu-Leu-Leu-AFC |
5.0 mg |
120 |
Acetyl-Leu-Leu-Leu-AFC |
Acetyl-Lys-Gln-Lys-Leu-Arg-4-methoxy-2-naphtylamide |
5.0 mg |
120 |
Acetyl-Lys-Gln-Lys-Leu-Arg-4-methoxy-2-naphtylamide |
Acetyl-Lys-Pro-Arg-AFC |
5.0 mg |
120 |
Acetyl-Lys-Pro-Arg-AFC |
Acetyl-Lys-Pro-Arg-AMC |
5.0 mg |
110 |
Acetyl-Lys-Pro-Arg-AMC |
Acetyl-Neurotensin (8-13) |
1.0 mg |
35 |
Acetyl-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
Acetyl-Neurotensin (8-13) |
5.0 mg |
105 |
Acetyl-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
Acetyl-Phe-Ile-Pro-Ala-Ser-Leu-Arg-AFC |
5.0 mg |
150 |
Acetyl-Phe-Ile-Pro-Ala-Ser-Leu-Arg-AFC |
Acetyl-Phe-Ser-Arg-pNA |
5.0 mg |
90 |
Acetyl-Phe-Ser-Arg-pNA |
Acetyl-Pro-Glu-Asp-Glu-AFC |
5.0 mg |
120 |
Acetyl-Pro-Glu-Asp-Glu-AFC |
Acetyl-Pro-Leu-Ser-Ser-Ile-Phe-Ser-Arg-Ile-Gly-Asp-Pro-Arg-Lys-Gly-Asp-Glu-Val-Asp-AFC |
5.0 mg |
185 |
Acetyl-Pro-Leu-Ser-Ser-Ile-Phe-Ser-Arg-Ile-Gly-Asp-Pro-Arg-Lys-Gly-Asp-Glu-Val-Asp-AFC |
Acetyl-Ser-Asp-Lys-Pro |
5.0 mg |
35 |
Acetyl-Ser-Asp-Lys-Pro |
Acetyl-Val-Glu-Ile-Ala-AFC |
5.0 mg |
120 |
Acetyl-Val-Glu-Ile-Ala-AFC |
ACTH (1-17) human |
1.0 mg |
80 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-OH |
ACTH (1-17) human |
5.0 mg |
315 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-OH |
ACTH (1-24), human |
1.0 mg |
80 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH |
ACTH (1-24), human |
5.0 mg |
315 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH |
ACTH (1-39), rat |
1.0 mg |
205 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH |
ACTH (7-38), human / Corticotropin Inhibiting Peptide (7-38) |
1.0 mg |
120 |
Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-OH |
ACTH (7-38), human / Corticotropin Inhibiting Peptide (7-38) |
5.0 mg |
485 |
Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-OH |
ADAM substrate |
1.0 mg |
230 |
(Glu-EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-(Dabcyl-Lys)-NH2 |
ADAM substrate |
5.0 mg |
895 |
(Glu-EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-(Dabcyl-Lys)-NH2 |
Adamantaneacetyl-[DArg0,Hyp3,Thi5,8,DPhe7] Bradykinin |
1.0 mg |
60 |
Adamataneacetyl-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg-OH |
Adamantaneacetyl-[DArg0,Hyp3,Thi5,8,DPhe7] Bradykinin |
5.0 mg |
210 |
Adamataneacetyl-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg-OH |
Adrenal Secretogranin, bovine |
5.0 mg |
155 |
Phe-Pro-Lys-Pro-Ala-Gly-Ser-Gln-Asp-Lys-Pro-Leu-His-Asn-OH |
Adrenomedullin (1-50), rat |
0.5 mg |
310 |
Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 |
Adrenomedullin (1-50), rat |
1.0 mg |
500 |
Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 |
Adrenomedullin (1-52), human |
0.5 mg |
310 |
Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 |
Adrenomedullin (1-52), human |
1.0 mg |
500 |
Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 |
Adrenomedullin (11-50), rat |
0.5 mg |
230 |
Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 |
Adrenomedullin (11-50), rat |
1.0 mg |
395 |
Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 |
Adrenomedullin (22-52), human |
0.5 mg |
160 |
Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 |
Adrenomedullin (22-52), human |
1.0 mg |
240 |
Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 |
Agatoxin IVa ( SS Cys 4,20 / Cys 12,25 / Cys 19,36 / Cys 27 |
0.5 mg |
835 |
Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala-OH |
Agatoxin IVa ( SS Cys 4,20 / Cys 12,25 / Cys 19,36 / Cys 27 |
1.0 mg |
1525 |
Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala-OH |
Akt Substrate |
5.0 mg |
105 |
Arg-Pro-Arg-Ala-Ala-Thr-Phe-NH2 |
All D Beta Amyloid (1-40), human |
0.5 mg |
395 |
D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-OH |
All D Beta Amyloid (1-40), human |
1.0 mg |
685 |
D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-OH |
Allatostatin B2, cockroach |
1.0 mg |
105 |
Ala-Tyr-Ser-Tyr-Val-Ser-Glu-Tyr-Lys-Arg-Leu-Pro-Val-Tyr-Asn-Phe-Gly-Leu-NH2 |
Alpha Atrial Natriuretic Polypeptide (1-28), human / ANP (1- |
0.5 mg |
125 |
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH |
Alpha Atrial Natriuretic Polypeptide (1-28), human / ANP (1- |
1.0 mg |
205 |
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH |
Alpha MSH Ac-Nle4 c[Asp5, D-Phe7, Lys10] (4-10) amide |
1.0 mg |
60 |
Acetyl-050-Asp-His-011-Arg-Trp-Lys-NH2 |
Alpha MSH Ac-Nle4 c[Asp5, D-Phe7, Lys10] (4-10) amide |
5.0 mg |
215 |
Acetyl-050-Asp-His-011-Arg-Trp-Lys-NH2 |
|
1.0 mg |
60 |
Acetyl-Ser-Tyr-Ser-Met-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2 |
Alpha MSH [D-Phe7] |
5.0 mg |
215 |
Acetyl-Ser-Tyr-Ser-Met-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2 |
Alpha MSH [Nle4,D-Phe7] |
1.0 mg |
60 |
Acetyl-Ser-Tyr-Ser-050-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2 |
Alpha MSH [Nle4,D-Phe7] |
5.0 mg |
215 |
Acetyl-Ser-Tyr-Ser-050-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2 |
Alpha MSH, Ac-NLe4c[Asp5,DNal7,Lys10](4-10) amide |
1.0 mg |
60 |
Acetyl-050-Asp-His-038-Arg-Trp-Lys-NH2 |
Alpha MSH, Ac-NLe4c[Asp5,DNal7,Lys10](4-10) amide |
5.0 mg |
215 |
Acetyl-050-Asp-His-038-Arg-Trp-Lys-NH2 |
Amylin (1-37) NH2, human / Islet Amyloid Polypeptide (IAPP), |
1.0 mg |
295 |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
Amylin (1-37) NH2, human / Islet Amyloid Polypeptide (IAPP), |
5.0 mg |
1315 |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
Amylin (1-37) NH2, human / Islet Amyloid Polypeptide (IAPP), |
10.0 mg |
2520 |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
Amylin, rat |
0.5 mg |
135 |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
Amylin, rat |
1.0 mg |
230 |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
Amyloid Blocker |
5.0 mg |
85 |
Acetyl-Gln-Lys-Leu-Val-Phe-Phe-NH2 |
Amyloid fragment (Pro18,Asp21) (17-21) |
5.0 mg |
105 |
Leu-Pro-Phe-Phe-Asp-OH |
Amyloid precursor |
1.0 mg |
135 |
Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-(DNP-Lys)-Arg-Arg-NH2 |
Amyloid precursor |
5.0 mg |
525 |
Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-(DNP-Lys)-Arg-Arg-NH2 |
Angiotensin Fragment ( 1-7 ) Acetate |
5.0 mg |
55 |
Asp-Arg-Val-Tyr-Ile-His-Pro-OH |
Angiotensin I [Asn1,Val5,Asn9], salmon |
1.0 mg |
30 |
Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH |
Angiotensin I [Asn1,Val5,Asn9], salmon |
5.0 mg |
105 |
Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH |
Angiotensin I [Val5,Asn9], bullfrog |
1.0 mg |
30 |
Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH |
Angiotensin I [Val5,Asn9], bullfrog |
5.0 mg |
105 |
Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH |
Angiotensin I/II (1-5) |
1.0 mg |
45 |
Asp-Arg-Val-Tyr-Ile-OH |
Angiotensin II [Sar1,Ile8] |
1.0 mg |
30 |
034-Arg-Val-Tyr-Ile-His-Pro-Ile-OH |
Angiotensin II [Sar1,Ile8] |
5.0 mg |
100 |
034-Arg-Val-Tyr-Ile-His-Pro-Ile-OH |
Angiotensin II, human |
5.0 mg |
35 |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
Angiotensin II-[Sar1] |
5.0 mg |
80 |
034-Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
Angiotensin III, human) / Angiotensin II-[Des Asp1] |
10.0 mg |
55 |
Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
Angiotensinogen (1-14) Renin Substrate (porcine) |
1.0 mg |
40 |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH |
Angiotensinogen (1-14) Renin Substrate (porcine) |
10.0 mg |
185 |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH |
ANP (123-150), rat / ANP (6-33), rat / ANP (1-28), rat |
0.5 mg |
125 |
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH |
ANP (123-150), rat / ANP (6-33), rat / ANP (1-28), rat |
1.0 mg |
205 |
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH |
ANP (126-150), rat / Auriculin B, ANP (4-28), rat |
0.5 mg |
125 |
Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH |
ANP (126-150), rat / Auriculin B, ANP (4-28), rat |
1.0 mg |
205 |
Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH |
ANP (4-24), frog |
1.0 mg |
165 |
Cys-Phe-Gly-Ser-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Met-Gly-Cys-Gly-Arg-Arg-Phe-OH |
ANP Des[18-22] (4-23) amide, rat |
1.0 mg |
125 |
Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Cys-NH2 |
Antennapedia Peptide |
1.0 mg |
80 |
Arg – Gln – Ile – Lys – Ile – Trp – Phe – Gln – Asn – Arg – Arg – Met – Lys – Trp – Lys – Lys |
Apamin, bee venom (SS1-11)(SS3-15) |
0.5 mg |
105 |
Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-Arg-Cys-Gln-Gln-His-NH2 |
Apamin, bee venom (SS1-11)(SS3-15) |
1.0 mg |
160 |
Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-Arg-Cys-Gln-Gln-His-NH2 |
APP (354-371) |
1.0 mg |
135 |
Lys-Ala-Val-Ile-Gln-His-Phe-Gln-Glu-Lys-Val-Glu-Ser-Leu-Glu-Gln-Glu-Ala-OH |
APP (354-371) |
5.0 mg |
525 |
Lys-Ala-Val-Ile-Gln-His-Phe-Gln-Glu-Lys-Val-Glu-Ser-Leu-Glu-Gln-Glu-Ala-OH |
APP Beta Secretase Inhibitor |
1.0 mg |
160 |
Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-200-Val-Ala-Glu-Phe-OH |
APP gamma secretase inhibitor |
5.0 mg |
60 |
3-5 difluorophenacetyl-Ala-217-t-Butylester |
APP gamma secretase inhibitor |
5.0 mg |
60 |
3-5 difluorophenacetyl-Ala-(S-Phenylglycine)-Methylester |
Arg-Glu(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-(e-Dabcyl-Lysine)-Arg-OH |
1.0 mg |
135 |
Arg-Glu(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-(e-Dabcyl-Lysine)-Arg-OH |
Arg-Leu-Lys-Gly-Gly-AFC |
5.0 mg |
140 |
Arg-Leu-Lys-Gly-Gly-AFC |
Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln-OH |
5.0 mg |
120 |
Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln-OH |
Asp-Glu-Val-Asp-AFC |
5.0 mg |
120 |
Asp-Glu-Val-Asp-AFC |
Atriopeptine III, rat;ANP (127-150), rat |
0.5 mg |
115 |
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH |
Atriopeptine III, rat;ANP (127-150), rat |
1.0 mg |
185 |
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH |
Autocamptide-2 Related Inhibitoy Peptide |
5.0 mg |
105 |
Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu-OH |
Autocamptide-2 Related Inhibitoy Peptide |
5.0 mg |
105 |
Myristoyl-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu-OH |
BAM (6-22) Quote : 6920 |
0.5 mg |
125 |
Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH |
BAM (6-22) Quote : 6920 |
1.0 mg |
185 |
Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH |
BAM 3200 Bovine Adrenal Medulla Peptide E |
0.5 mg |
175 |
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu-OH |
BAM 3200 Bovine Adrenal Medulla Peptide E |
1.0 mg |
290 |
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu-OH |
Beta Amyloid (1-16) [Gln11], human |
0.5 mg |
60 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-OH |
Beta Amyloid (1-16) [Gln11], human |
1.0 mg |
85 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-OH |
Beta Amyloid (1-16) [Gln11], human |
5.0 mg |
320 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-OH |
Beta Amyloid (1-16), rat |
1.0 mg |
90 |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-OH |
Beta Amyloid (1-16), rat |
5.0 mg |
340 |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-OH |
Beta Amyloid (1-28), [Gln11], human |
0.5 mg |
95 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH |